Volume 9, Numbers 1-3, 143-147, DOI: 10.1007/BF02628672

Dialysable lymphocyte extract (DLyE) in infantile onset autism: A pilot study

H. H. Fudenberg

View Related Documents

Abstract

40 infantile autistic patients were studied. They ranged from 6 years to 15 years of age at entry. 22 were cases of classical infantile autism; whereas 18 lacked one or more clinical defects associated with infantile autism (“pseudoautism”). Of the 22 with classic autism, 21 responded to transfer factor (TF) treatment by gaining at least 2 points in symptoms severity score average (SSSA); and 10 became normal in that they were main-streamed in school and clinical characteristics were fully normalized. Of the 18 remaining, 4 responded to TF, some to other therapies. After cessation of TF therapy, 5 in the autistic group and 3 of the pseudo-autistic group regressed, but they did not drop as low as baseline levels.

Key words  Autism - dialysable lymphocyte extract - transfer factor

Fulltext Preview

Image of the first page of the fulltext document